Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Maestro

Showing results (31-40 of 103) with videos related to

Pageof 11
Sort By:
The American Journal of Pathology|November 25, 2003
Alterations of beta-catenin pathway in non-melanoma skin tumors: loss of alpha-ABC nuclear reactivity correlates with the presence of beta-catenin gene mutationClaudio Doglioni, Sara Piccinin, Silvia Demontis, et al.
Molecular Genetics & Genomic Medicine|March 28, 2019
Toward a better definition of EPCAM deletions in Lynch Syndrome: Report of new variants in Italy and the associated molecular phenotypeGiulia Cini, Michele Quaia, Vincenzo Canzonieri, et al.
The Journal of Pathology|November 27, 2015
Transcriptome sequencing identifies ETV6-NTRK3 as a gene fusion involved in GISTMonica Brenca, Sabrina Rossi, Maurizio Polano, et al.
The American Journal of Surgical Pathology|April 10, 2020
Primary Vascular Tumors of Bone: A Monoinstitutional Morphologic and Molecular Analysis of 427 Cases With Emphasis on Epithelioid VariantsAlberto Righi, Marta Sbaraglia, Marco Gambarotti, et al.
Molecular Cancer Therapeutics|April 12, 2013
SMARCB1/INI1 genetic inactivation is responsible for tumorigenic properties of epithelioid sarcoma cell line VAESBJMonica Brenca, Sabrina Rossi, Erica Lorenzetto, et al.
Molecular Cancer Therapeutics|August 3, 2021
Correction: SMARCB1/INI1 Genetic Inactivation Is Responsible for Tumorigenic Properties of Epithelioid Sarcoma Cell Line VAESBJMonica Brenca, Sabrina Rossi, Erica Lorenzetto, et al.
JCI Insight|October 13, 2020
Tumor genotype, location, and malignant potential shape the immunogenicity of primary untreated gastrointestinal stromal tumorsDaniela Gasparotto, Marta Sbaraglia, Sabrina Rossi, et al.
Oncotarget|December 29, 2011
Overexpression of TWIST2 correlates with poor prognosis in head and neck squamous cell carcinomasDaniela Gasparotto, Jerry Polesel, Alessandra Marzotto, et al.
Molecular and Cellular Biology|September 18, 2013
MEF2 is a converging hub for histone deacetylase 4 and phosphatidylinositol 3-kinase/Akt-induced transformationEros Di Giorgio, Andrea Clocchiatti, Sara Piccinin, et al.
The Journal of Clinical Endocrinology and Metabolism|March 11, 2011
TWIST1 plays a pleiotropic role in determining the anaplastic thyroid cancer phenotypePaolo Salerno, Ginesa Garcia-Rostan, Sara Piccinin, et al.
Pageof 11

Showing results (31-40 of 103) with videos related to

Sort By:
Pageof 11
The American Journal of Pathology|November 25, 2003
Alterations of beta-catenin pathway in non-melanoma skin tumors: loss of alpha-ABC nuclear reactivity correlates with the presence of beta-catenin gene mutationClaudio Doglioni, Sara Piccinin, Silvia Demontis, et al.
Molecular Genetics & Genomic Medicine|March 28, 2019
Toward a better definition of EPCAM deletions in Lynch Syndrome: Report of new variants in Italy and the associated molecular phenotypeGiulia Cini, Michele Quaia, Vincenzo Canzonieri, et al.
The Journal of Pathology|November 27, 2015
Transcriptome sequencing identifies ETV6-NTRK3 as a gene fusion involved in GISTMonica Brenca, Sabrina Rossi, Maurizio Polano, et al.
The American Journal of Surgical Pathology|April 10, 2020
Primary Vascular Tumors of Bone: A Monoinstitutional Morphologic and Molecular Analysis of 427 Cases With Emphasis on Epithelioid VariantsAlberto Righi, Marta Sbaraglia, Marco Gambarotti, et al.
Molecular Cancer Therapeutics|April 12, 2013
SMARCB1/INI1 genetic inactivation is responsible for tumorigenic properties of epithelioid sarcoma cell line VAESBJMonica Brenca, Sabrina Rossi, Erica Lorenzetto, et al.
Molecular Cancer Therapeutics|August 3, 2021
Correction: SMARCB1/INI1 Genetic Inactivation Is Responsible for Tumorigenic Properties of Epithelioid Sarcoma Cell Line VAESBJMonica Brenca, Sabrina Rossi, Erica Lorenzetto, et al.
JCI Insight|October 13, 2020
Tumor genotype, location, and malignant potential shape the immunogenicity of primary untreated gastrointestinal stromal tumorsDaniela Gasparotto, Marta Sbaraglia, Sabrina Rossi, et al.
Oncotarget|December 29, 2011
Overexpression of TWIST2 correlates with poor prognosis in head and neck squamous cell carcinomasDaniela Gasparotto, Jerry Polesel, Alessandra Marzotto, et al.
Molecular and Cellular Biology|September 18, 2013
MEF2 is a converging hub for histone deacetylase 4 and phosphatidylinositol 3-kinase/Akt-induced transformationEros Di Giorgio, Andrea Clocchiatti, Sara Piccinin, et al.
The Journal of Clinical Endocrinology and Metabolism|March 11, 2011
TWIST1 plays a pleiotropic role in determining the anaplastic thyroid cancer phenotypePaolo Salerno, Ginesa Garcia-Rostan, Sara Piccinin, et al.
Pageof 11